Inovio Pharmaceuticals (INO) Times Interest Earned (2019 - 2024)
Historic Times Interest Earned for Inovio Pharmaceuticals (INO) over the last 6 years, with Q1 2024 value amounting to -$177.05.
- Inovio Pharmaceuticals' Times Interest Earned fell 2627.91% to -$177.05 in Q1 2024 from the same period last year, while for Dec 2024 it was -$632.05, marking a year-over-year decrease of 43693.26%. This contributed to the annual value of -$632.05 for FY2024, which is 43693.25% down from last year.
- Latest data reveals that Inovio Pharmaceuticals reported Times Interest Earned of -$177.05 as of Q1 2024, which was down 2627.91% from -$97.03 recorded in Q4 2023.
- In the past 5 years, Inovio Pharmaceuticals' Times Interest Earned ranged from a high of -$9.0 in Q1 2020 and a low of -$332.19 during Q2 2022
- In the last 5 years, Inovio Pharmaceuticals' Times Interest Earned had a median value of -$118.16 in 2023 and averaged -$128.94.
- Per our database at Business Quant, Inovio Pharmaceuticals' Times Interest Earned soared by 7930.31% in 2020 and then crashed by 142938.21% in 2021.
- Over the past 5 years, Inovio Pharmaceuticals' Times Interest Earned (Quarter) stood at -$27.47 in 2020, then crashed by 699.62% to -$219.67 in 2021, then grew by 18.76% to -$178.46 in 2022, then surged by 45.63% to -$97.03 in 2023, then crashed by 82.47% to -$177.05 in 2024.
- Its Times Interest Earned was -$177.05 in Q1 2024, compared to -$97.03 in Q4 2023 and -$113.41 in Q3 2023.